AngelEye Health Secures Additional $9 Million to Accelerate Innovation in Neonatal and Pediatric Care

AngelEye Health 获得额外 900 万美元融资，加速新生儿和儿科护理创新

New investment fuels the continued growth of its advanced NICU and Pediatric solutions, accelerating AIVision adoption

新投资推动其先进的新生儿重症监护室和儿科解决方案的持续增长，加速AIVision的采用。

NASHVILLE, Tenn., December 9, 2025-- AngelEye Health, a leader in neonatal and pediatric services, today announced the closing of a $9 million Series C funding round. In addition to the equity financing, AngelEye has secured a complementary debt facility from Live Oak Bank to strategically extend the company’s growth capital.

田纳西州纳什维尔，2025年12月9日——新生儿和儿科服务领域的领导者AngelEye Health今天宣布完成了900万美元的C轮融资。除了股权融资外，AngelEye还从Live Oak Bank获得了配套的债务融资，以战略性地扩展公司的成长资本。

The combined funding will enable AngelEye to accelerate product innovation, expand its commercial footprint, and further advance its mission to transform neonatal and pediatric inpatient units into intelligent, connected environments optimized for care delivery, efficiency, and family empowerment..

这笔联合资金将使AngelEye能够加速产品创新，扩大其商业版图，并进一步推进其使命，将新生儿和儿科住院病房转变为智能化、互联的环境，优化护理提供、效率和家庭赋权。

The round was led by existing investor Mountain Group Partners, with continued support from Brad Whitmore and additional existing investors. AngelEye is also pleased to welcome Nationwide Children’s Hospital as a new investor, underscoring a shared commitment to improving outcomes for vulnerable infants.

本轮融资由现有投资者Mountain Group Partners领投，Brad Whitmore和更多现有投资者持续支持。AngelEye还欣然迎来了新投资者Nationwide Children's Hospital，彰显了双方对改善脆弱婴儿预后的共同承诺。

In conjunction with the investment, Luke Brown, Vice President of Finance and Treasury at Nationwide Children’s Hospital will join AngelEye’s Board of Directors as an observer..

全国儿童医院财务与司库副总裁卢克·布朗将在此次投资的同时，以观察员身份加入AngelEye的董事会。

“AngelEye’s mission to empower families and equip care teams in the NICU and pediatric settings aligns strongly with our goals as a pediatric health leader,” said Mr. Brown.

“AngelEye赋权家庭和为新生儿重症监护室及儿科环境中的护理团队提供装备的使命，与我们作为儿科健康领域领导者的目标准确契合，”布朗先生说道。

The company is proud to announce that with the increasing adoption of its platform, AngelEye now provides services to over 350 hospitals who serve approximately 20% of the NICU families across the United States. Additionally, the Series C announcement follows several significant 2025 milestones for AngelEye, including its fourth consecutive appearance on the Inc.

公司自豪地宣布，随着其平台的采用率不断提高，AngelEye目前已为350多家医院提供服务，这些医院为美国约20%的新生儿重症监护室（NICU）家庭提供服务。此外，C轮融资公告紧随AngelEye在2025年的多个重要里程碑，其中包括连续第四年登上《Inc.》杂志榜单。

5000 list of America’s fastest-growing private companies, recognition as an Inc. Power Partner, and the achievement of SOC II Type 2 certification..

5000家美国增长最快的私营公司榜单，被评为Inc. Power Partner，以及获得SOC II Type 2认证。

“Our team has remained focused on one mission: helping hospitals provide comprehensive support for clinical teams and families alike, equipping them with the tools they need to stay connected, confident, and informed throughout the NICU journey,” said Christopher Rand, CEO of AngelEye Health. “This funding gives us the ability to bring AIVision to market while continuing to scale the solutions that have already made us a trusted partner to hundreds of hospitals nationwide.”.

“我们的团队一直专注于一项使命：帮助医院为临床团队和家庭提供全面支持，为他们配备在新生儿重症监护室（NICU）旅程中保持联系、信心和信息所需的工具，”AngelEye Health首席执行官克里斯托弗·兰德表示。“这笔资金使我们能够将AIVision推向市场，同时继续扩展那些已使我们成为全国数百家医院值得信赖的合作伙伴的解决方案。”

AngelEye’s platform has become a mainstay in NICU and PICU environments, enabling real-time family connection through secure livestream video, streamlining feeding workflows and documentation with MilkTracker, and guiding families through discharge readiness with NICU2Home. With the addition of AIVision, the company is advancing its value proposition by providing care teams with earlier, AI-driven insights, reinforcing its role as a critical partner in patient safety, family engagement, and operational efficiency..

天使眼的平台已成为新生儿重症监护室和儿科重症监护室环境中的重要组成部分，通过安全的直播视频实现家庭实时连接，利用MilkTracker简化喂养工作流程和文件记录，并通过NICU2Home引导家属做好出院准备。随着AIVision的加入，该公司正通过提供更早期的、由人工智能驱动的洞察来提升其价值主张，进一步巩固其在患者安全、家庭参与和运营效率方面的关键合作伙伴地位。

For more information about AngelEye Health, visit www.angeleyehealth.com.

有关 AngelEye Health 的更多信息，请访问 www.angeleyehealth.com。

About AngelEye Health

关于AngelEye Health

AngelEye Health is the leading provider of innovative technology solutions dedicated to transforming neonatal and pediatric care. Trusted by over 350 hospitals globally, AngelEye equips care teams with AI-driven tools designed to streamline workflows, reduce length of stay, minimize errors, and optimize resource allocation.

AngelEye Health 是致力于改变新生儿和儿科护理的创新技术解决方案的领先提供商。全球超过 350 家医院信赖 AngelEye，它为护理团队配备了人工智能驱动的工具，旨在简化工作流程、缩短住院时间、减少错误并优化资源配置。

Its comprehensive suite, including CameraSystem for family engagement, MilkTracker for precise feeding management, NICU2Home for efficient discharge planning, and EDNA for proactive risk identification, supports care teams and families at every step of the NICU journey. With a commitment to continuous innovation, AngelEye Health is shaping the NICU of the future, empowering families, enhancing clinical efficiency, and delivering measurable improvements in patient outcomes.

其全面的产品套件，包括用于家庭互动的CameraSystem、用于精确喂养管理的MilkTracker、用于高效出院规划的NICU2Home，以及用于主动风险识别的EDNA，支持护理团队和家庭在NICU旅程的每一步。凭借对持续创新的承诺，AngelEye Health正在塑造未来的NICU，赋予家庭权力，提高临床效率，并在患者结果方面带来可衡量的改善。

To learn more, visit angeleyehealth.com..

要了解更多信息，请访问angeleyehealth.com。

Contact:

联系人：

Media Contact

媒体联系人

Brynn Spicher

布赖恩·斯皮彻

anthonyBarnum Public Relations

安东尼·巴纳姆公共关系

brynn.spicher@anthonybarnum.com

布林·斯皮彻@安东尼巴纳姆.com